Tumor Immune Cell Targeting Chimeras (TICTACs) reprogram tumor-associated macrophages
Mariko Morimoto, David S. Roberts, Ru M. Wen…·Carolyn Ruth Bertozzi
The paper develops TICTACs, which selectively target and degrade checkpoint receptors on tumor-associated macrophages without affecting other cells.